The potential role of growth hormone on the endometrium in assisted reproductive technology
Date
2020
Authors
Liu, F.T.
Wu, Z.
Yan, J.
Norman, R.J.
Li, R.
Editors
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Journal article
Citation
Frontiers in Endocrinology, 2020; 11:49-1-49-8
Statement of Responsibility
Fen-Ting Liu, Ze Wu, Jie Yan, Robert J. Norman and Rong Li
Conference Name
Abstract
Growth hormone (GH) has been considered as an adjuvant treatment in human assisted reproductive technology (ART) for several years. Its action was largely attributed to an improvement of ovarian function and less emphasis was paid to its role in the uterus. However, there is increasing evidence that GH and its receptors are expressed and have actions in the endometrium and may play an important role in modifying endometrial receptivity. Thus, in this review, we firstly describe the existence of GH receptors in endometrium and then summarize the effects of GH on the endometrium in clinical situations and the underlying mechanisms of GH in the regulation of endometrial receptivity. Finally, we briefly review the potential risks of GH in ART and consider rationalized use of GH treatment in ART.
School/Discipline
Dissertation Note
Provenance
Description
Access Status
Rights
© 2020 Liu, Wu, Yan, Norman and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.